Please log in to view this page
Username
Password
A5329 is a study for people who are infected with both HIV and the Hepatitis C virus (HCV) and have never taken Hepatitis C...
The purpose of this study is to obtain informed consent to use stored human biological materials (HBM) (e.g., blood and other...
This study is currently on hold. The study is designed to characterize the pharmacokinetics of DLM using a model-based...
REPRIEVE (A5332) is a large double-blind, randomized, placebo-controlled study of pitavastatin or placebo for about 72 months....
Rationale: There is an urgent need for a platform to rapidly evaluate therapies in the outpatient setting, to prevent disease...
